Press Release

Regenerative Medicine Market: 2019 Market Share, Competitive Landscape, Key Players, Worldwide Opportunities

Regenerative Medicine Market Expansion to be Persistent During 2019 – 2026, says Fortune Business Insights

Fortune Business Insights states that The Regenerative Medicine Market will reach US$ 151,949.5 Mn by the end of 2026, thereby exhibiting a CAGR of 26.1%.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/regenerative-medicine-market-100970

Fortune Business Insights some of the leading companies that have made significant growth contributions to the global market. Besides this, the report identifies some of the attractive business strategies that have been adopted by renowned companies in the world. Some of the leading companies that are operating in the market are

  • Integra LifeSciences Corporation,
  • CELGENE CORPORATION,
  • Medtronic,
  • American CryoStem Corporation,
  • Tissue Regenix,
  • Avita Medical,
  • Osiris Therapeutics, Inc.,
  • Wright Medical Group N.V.,
  • Smith & Nephew,
  • Integra LifeSciences Corporation.

Segmentation

By Product

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Platelet Rich Plasma

By Application

  • Orthopedics
  • Wound Care
  • Oncology
  • Others

By Distribution Channel

  • Hospitals
  • Clinics

Recent developments in treatment of acute and chronic diseases can be attributed to advances in regenerative medicines. Regenerative medicine mainly focus on identifying the root cause of the disease and aims at locating, repairing, and regenerating the non-functioning body cells. As most of the chronic and acute diseases are inclined towards the elderly and geriatric population, the growing geriatric population serves growth of the global regenerative medicine market in the coming years. The ability of regenerative medicine to reduce the burden for some of the most severe chronic diseases will create a high demand for the products in the coming years. Furthermore, applications of regenerative medicine in treatment of diabetic ulcers and chemotherapy will favor the growth of the market in the forthcoming years.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/regenerative-medicine-market-100970

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases
Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close